Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2011-01-11
2011-01-11
Puttlitz, Karl J (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
Reexamination Certificate
active
07868047
ABSTRACT:
The present invention provides novel methods of treating psoriasis, protein tyrosine kinase-associated disorders, inflammation, epidermal hyperproliferation, diabetes, immune and autoimmune diseases, eczema, and inflammatory bowel disease, inhibiting protein kinase, neutrophil activation, cell proliferation, tumour growth, metastasis, and the development of atheromatous plaque and restonosis, controlling angiogenesis, and preventing inflammatory bowel disease, using hydroxystilbenes and novel stilbene derivatives.
REFERENCES:
patent: 4186196 (1980-01-01), Lasher
patent: 4723028 (1988-02-01), Shudo
patent: 4788304 (1988-11-01), Marshall et al.
patent: 4876381 (1989-10-01), Lang et al.
patent: 4933365 (1990-06-01), Marshall et al.
patent: 5472715 (1995-12-01), Uehara
patent: 5547983 (1996-08-01), Charpentier
patent: 5556996 (1996-09-01), Beard et al.
patent: 6008260 (1999-12-01), Pezzuto et al.
patent: 6410596 (2002-06-01), Hopp et al.
patent: 6552085 (2003-04-01), Inman et al.
patent: 6790869 (2004-09-01), Ghai et al.
patent: 2003/0073712 (2003-04-01), Wang et al.
patent: 2266763 (1999-10-01), None
patent: 2433417 (2002-07-01), None
patent: 2501663 (2004-04-01), None
patent: 0170105 (1985-07-01), None
patent: 0558950 (1996-04-01), None
patent: 2785284 (1998-02-01), None
patent: 1465661 (1977-02-01), None
patent: 58159410 (1983-09-01), None
patent: 07053359 (1995-02-01), None
patent: 08337523 (1996-12-01), None
patent: 10072330 (1998-03-01), None
patent: 9216486 (1992-10-01), None
patent: 9219583 (1992-11-01), None
patent: 9940056 (1999-08-01), None
patent: 9959561 (1999-11-01), None
patent: 0026167 (2000-05-01), None
patent: 0142231 (2001-06-01), None
patent: 0195859 (2001-12-01), None
Amson, R., et al. “The human protoncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias”, Proc. Natl. Acad. Sci., 86:8857-8861, 1989.
Ark, et al., “Mapping of the Pim-1oncogene in mouse t-haplotypes and its use to define the relative Map position of the tcl Loci to(t6) and T212 and the market tf(tufted)”, Genomics, 10:385-389, 1991.
Bezou, et al., “Efficient synthesis of p-vinyl-trans-stilbene”, Synthesis, 449-451, 1996.
Campbell, et al., “Association between b-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinases”, Mol. & Cell. Biol., 12(5):2315-2321, 1992.
Cushman, et al., “Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3-4-5-trimethoxyphenyl) ethene as potential cytotoxic and antimitotic agents”, J. Med. Chem., 33:2293-2306, 1992.
Dudek, et al., “Synthesis of ferrocenethiols containing oligo(phenylenevinylene) bridges and their characterization on gold electrodes”, J. Am. Chem. Soc., 13:8033-8038, 2001.
Eicher, et al., “Synthese von bryophyten-inhalsstoffen 2. Synthesen von prenylierten bibenzyl-derivaten”, Synthesis, 30:98-102, 1991.
Fang, et al., “Flavonoids and stilbenes from armand pine”, Phytochem., 27(5):1395-1397, 1988.
Garcia-Garcia, et al., “The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity”, Arch of Biochem & Biophys., 372(2):382-388, 1999.
Hu, et al. “Comparison of metabolites produced in vitro and in vivo by Photorhabdus luminescens, a bacterial symbiont of the entomopathogenic nematode Heterorhabditis megidis”, Can. J. Microbiol. 44:1072-1077, 1998.
Jang, et al., “Cancer chemopreventive activity of resveratrol, a natural product derived from grapes”, Science, 175:218-220, 1997.
Krow, et al., “Synthesis of antibiotic stilbenes using organomanganese arene complexes”, J. Org. Chem., 57:4040-4043, 1992.
Laird, et al., “In vivo analysis of pim-1 deficiency”, Nuc. Acids. Res., 21(20):4750-4755, 1993.
Paul, et al., “Antibiotics in microbial ecology—isolation and structure assignment of several new antibacterial compounds from the insect-symbiotic bacteria Xenorhabdus spp,” J. of Chem. Ecol., 7(3):589-597, 1981.
Saris, et al., “The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG”, EMBO J., 10(3):655-664, 1991.
Seguineau, et al., “The Wittig-Horner reaction in heterogenous media—X: Synthesis of alpha-deuterated functional olefins using potassium carbonate with Deuterium oxide”, Tetrahedron Letters, 29(4):477-480, 1988.
Syah, et al., “Andalasin A, a new stilbene dimer from Morus macroura”, Fitoterapia, 71:630-635, 2000.
Thakkar, et al., “Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol”, J. Med. Chem., 36:2950-2955, 1993.
Treadwell, et al., “A cascade cyclization approach to schweinfurthin B”, Org. Lett., 4(21):3639-3642, 2002.
Tudan, et al. “Selective inhibition of protein kinase C, mitogen-activated protein kinase, and neutrophil activation in response to calcium pyrophosphate dihydrate crystals, formyl-methionyl-leucyl-phenylalanine, and phorbol ester by O- (chloracetyl-carbamoyl) fumagillol (AGM-470;TNP-470)”, Biochem. Pharm., 58:1869-1880, 1999.
Beutler, J.A., et al. “Cytotoxic geranyl stilbenes from macaranga schweinfurthii”, CA 130:49807, 1998.
Majima, Tetsuro, et al., “Cis-trans isomerization and oxidation of radical cations of stilbene derivatives”, J. Org. Chem., 61:7793-7800, 1996.
Ney, M., et al., “Anti-inflammatory effects of synthetic retinoids may be related to their immunomodulatory action”, Dermatologica, 175:Suppl. 1, 93-99, 1987.
Shimizu, K., et al. “The inhibitory components from artocarpus incisus on melanin biosynthesis”, CA 129:166112, 1998.
Chen Genhui
Hu Kaji
Li Jianxiong
Liu Wei
Webster John M.
Oyen Wiggs Green & Mutala LLP
Puttlitz Karl J
Welichem Biotech Inc.
LandOfFree
Anti-inflammatory and psoriasis treatment and protein kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory and psoriasis treatment and protein kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory and psoriasis treatment and protein kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2723722